AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Revenue growth (%)

ROHTO PHARMACEUTICAL CO.,LTD.【JP:4527】

Market cap
¥570.4B
P/E ratio
16.5x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 202514+3.49%
Mar 31, 202413.5-31.01%
Mar 31, 202319.5+92.89%
Mar 31, 202210.1-370.86%
Mar 31, 2021-3.7-244.96%
Mar 31, 20202.6-62.55%
Mar 31, 20196.9-37.87%
Mar 31, 201811.1-249.26%
Mar 31, 2017-7.4-174.00%
Mar 31, 201610+81.56%
Mar 31, 20155.5-51.32%
Mar 31, 201411.4+54.35%
Mar 31, 20137.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)